Hyperguides

Rheumatology / Rheumatology

Treatment Escalation in a Newly Diagnosed Patient

Leonard H. Calabrese, DO
Course overview
EXPERT VIDEOIBECCMECNE
Author(s)/Faculty: Leonard H. Calabrese, DO
Release Date: 7/19/2016Expiration Date: 7/18/2017
Credit Type: CME / CNENumber of Credits: 0.25
Content Type: VideoProvider:
In this Curbside Consult, Leonard H. Calabrese, DO and Elizabeth Kirchner, MSN, CNP describe the underlying principles of innate and adaptive immunity as they contribute to understanding the mechanism of action of existing and developing immune-based therapies...
CME Information

Support Statement: This activity is supported by educational grants from Bristol-Myers Squibb, Lilly, and Pfizer.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

Target Audience: The intended audience for this activity is rheumatologists, rheumatology nurses and other health care professionals involved in the treatment of patients with rheumatoid arthritis (RA).

Purpose/Learning Objectives: Upon successful completion of this educational activity, participants should be better able to examine the immunopathogenesis and therapeutic landscape of RA and allied conditions as well as strategies to mitigate risk from biologic and immune-based agents.

Activity Chair:
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Director of the R.J. Fasenmyer Center for Clinical Immunology
Cleveland Clinic
Cleveland, OH

Faculty:
Elizabeth Kirchner, MSN, CNP
Cleveland Clinic
Cleveland, OH

Reviewers:
Kevin D. Deane, MD, PhD
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP

Nurse Planner:
Barbara Niedz, PhD, RN, CPHQ

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 0.25 hours credit for completing this program.

This enduring material is approved for 1 year from the date of original release, July 19, 2016 to July 18, 2017.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

Steering Committee and Faculty report the following relationship(s):
Leonard H. Calabrese, DO
Consulting Fee: GlaxoSmithKline, Janssen, Pfizer, Sanofi
Speakers Bureau: AbbVie, Bristol-Myers Squibb, Crescendo, Genentech, Janssen

Joseph E. Craft, MD
Non-CME Services Fees: Bristol-Myers Squibb, MedImmune

John J. Cush, MD
Consulting Fee: AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Janssen, Lilly, Novartis, Pfizer, UCB Clinical Investigator: AbbVie, AstraZeneca, Celgene, Janssen, Novartis, Pfizer

Elizabeth Kirchner, MSN, CNP
Consulting Fee: Pfizer, Sanofi
Speakers Bureau: Crescendo Bioscience

William F.C. Rigby, MD
Consulting Fee: Bristol-Myers Squibb, Lilly, Pfizer, Roche
Non-CME Services Fees: Bristol-Myers Squibb
Contracted Research: Amgen, Bristol-Myers Squibb, Pfizer, Roche

Sergio Schwartzman, MD
Consulting Fee: AbbVie, Crescendo, Epirus, Genentech, Hospira, Janssen, Novartis, Pfizer, Regeneron
Speakers Bureau: AbbVie, Crescendo, Genentech, Hospira, Janssen, Novartis, Pfizer
Ownership Interest: Amgen, Gilead, Medtronic, Pfizer
Board Member: Discus-Analytics National Psoriasis Foundation Scientific Advisory Board Member: Bioscience, Crescendo

Gregg Silverman, MD
Consulting Fee:Bristol-Myers Squibb, Genentech
Speakers Bureau: Genentech

Reviewers report the following relationship(s):
Kevin Deane, MD
Consulting Fee: Janssen
Honoraria: Medscape

Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Nurse Planner reports the following relationship(s):
Barbara Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.